πŸ‡ΊπŸ‡Έ FDA
Patent

US 11173164

Compositions comprising triterpenoids

granted A61KA61K31/122A61K31/56

Quick answer

US patent 11173164 (Compositions comprising triterpenoids) held by REGENERA PHARMA LTD. expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERA PHARMA LTD.
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/122, A61K31/56, A61K31/569, A61K31/575